Arcadia Biosciences Inc. (RKDA) Financial Statements (2024 and earlier)

Company Profile

Business Address 202 COUSTEAU PLACE
DAVIS, 95618
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 01 - Agricultural Production Crops (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments11,64220,64428,68525,66725,33221,823
Cash and cash equivalents6,51820,64428,68514,0428,41711,998
Short-term investments5,124  11,62516,9159,825
Receivables (3)1,3701,406602168
Inventory, net of allowances, customer advances and progress billings1,9582,5714,4333,8121,794181
Inventory1,9582,5714,4333,8121,794181
Deferred costs     226197
Disposal group, including discontinued operation      
Asset, held-for-sale, not part of disposal group 5187    
Other undisclosed current assets1,3212,099900811486507
Total current assets:14,97225,39835,38831,69628,44022,876
Noncurrent Assets
Inventory, Noncurrent3,3547672,4943,485364746
Operating lease, right-of-use asset7921,8483,0815,8261,963
Property, plant and equipment3847042,2913,5391,799395
Long-term investments and receivables      
Accounts and financing receivable, after allowance for credit loss      
Intangible assets, net (including goodwill)3940484778  
Goodwill    408  
Intangible assets, net (excluding goodwill)3940484370  
Restricted cash and investments    2,001  
Other noncurrent assets1641651802387
Total noncurrent assets:4,7333,5248,53015,6524,1341,148
TOTAL ASSETS:19,70528,92243,91847,34832,57424,024
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:2,4102,8813,6384,1054,6852,645
Employee-related liabilities1,6061,4891,2901,096
Accounts payable 8019311,411726492285
Accrued liabilities 1,3911,746271592598648
Other undisclosed accounts payable and accrued liabilities2182043501,2982,305616
Deferred revenue    842
Debt    1,141635 
Disposal group, including discontinued operation      
Other liabilities  270264263306284
Due to related parties4864804029
Contract with customer, liability96
Other undisclosed current liabilities1,1801,0101,074717  
Total current liabilities:3,5904,2095,0406,3145,7083,054
Noncurrent Liabilities
Long-term debt and lease obligation   2,2207,4941,604 
Long-term debt, excluding current maturities    2,105107 
Liabilities, other than long-term debt2,1553,0072,0702,2802,0003,072
Other liabilities2,0002,0002,0702,2802,0003,072
Operating lease, liability1551,0072,2205,3891,497
Other undisclosed noncurrent liabilities1,2578063,3922,70814,9365,083
Total noncurrent liabilities:3,4123,8137,68212,48218,5408,155
Total liabilities:7,0028,02212,72218,79624,24811,209
Equity
Equity, attributable to parent12,84121,03331,09327,7257,70512,815
Common stock656563544945
Additional paid in capital284,515278,827257,515239,496214,826191,136
Accumulated other comprehensive income101   1 
Accumulated deficit(271,840)(257,859)(226,485)(211,825)(207,171)(178,366)
Equity, attributable to noncontrolling interest(138)(133)103827621 
Total equity:12,70320,90031,19628,5528,32612,815
TOTAL LIABILITIES AND EQUITY:19,70528,92243,91847,34832,57424,024

Income Statement (P&L) ($ in thousands)

6/30/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues5,3309,9566,7808,0341,1691,464
Cost of revenue(3,393)(9,802)(13,390)(4,311)(304)(310)
Cost of goods and services sold(3,300)(9,802)(8,708)(4,311)(304)(310)
Gross profit:1,937154(6,610)3,7238651,154
Operating expenses(15,875)(19,557)(28,916)(20,812)(20,550)(18,334)
Other undisclosed operating income  588 4,311304310
Operating loss:(13,938)(18,815)(35,526)(12,778)(19,381)(16,870)
Nonoperating income
(Other Nonoperating income)
483310,114740466394
Interest and debt expense   (20)(682)(5) 
Loss from continuing operations before equity method investments, income taxes:(13,890)(18,782)(25,432)(12,720)(18,920)(16,476)
Other undisclosed income (loss) from continuing operations before income taxes7333,1849,3006,570(9,951)3,006
Loss from continuing operations before income taxes:(13,157)(15,598)(16,132)(6,150)(28,871)(13,470)
Income tax expense (benefit)(8)(14)(2)124(2)(10)
Other undisclosed income from continuing operations      
Loss from continuing operations:(13,165)(15,612)(16,134)(6,026)(28,873)(13,480)
Loss before gain (loss) on sale of properties:(16,134)(6,026)(28,873)(13,480)
Loss from discontinued operations(821)     
Other undisclosed net loss      
Net loss:(13,986)(15,612)(16,134)(6,026)(28,873)(13,480)
Net income attributable to noncontrolling interest 52361,4741,37168 
Net loss available to common stockholders, diluted:(13,981)(15,376)(14,660)(4,655)(28,805)(13,480)

Comprehensive Income ($ in thousands)

6/30/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(13,986)(15,612)(16,134)(6,026)(28,873)(13,480)
Other comprehensive income (loss)101  (1)1 
Comprehensive loss:(13,885)(15,612)(16,134)(6,027)(28,872)(13,480)
Comprehensive income, net of tax, attributable to noncontrolling interest 52361,4741,37168 
Other undisclosed comprehensive loss, net of tax, attributable to parent      
Comprehensive loss, net of tax, attributable to parent:(13,880)(15,376)(14,660)(4,656)(28,804)(13,480)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: